{"filing":{"accession_number":"0001213900-26-064278","cik":"0001860657","ticker":"ALLR","company_name":"Allarity Therapeutics, Inc.","form":"8-K","filing_date":"2026-06-02","report_date":null,"primary_document":"ea0293097-8k_allarity.htm","primary_document_url":"https://www.sec.gov/Archives/edgar/data/1860657/000121390026064278/ea0293097-8k_allarity.htm"},"events":[{"id":7525,"run_id":6612,"accession_number":"0001213900-26-064278","anchor_item_number":"5.02","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.35,"summary":"The section header indicates Item 5.02 disclosure covering departures, elections, appointments, and/or compensatory arrangements, but the actual prose content was not provided. Without the specific details of what occurred (e.g., whether an executive departed, was appointed, received compensation, or some combination), I cannot reliably classify this into a more specific event type. I am marking it as material because Item 5.02 disclosures typically involve material executive changes, but the confidence is low due to missing content.","company_name":"Allarity Therapeutics, Inc.","ticker":"ALLR","filing_date":"2026-06-02","form":"8-K","submitted_at":null,"items":[{"id":3653,"accession_number":"0001213900-26-064278","item_number":"5.02","item_title":"Departure of Directors or Certain","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.35,"reasoning":"The section header indicates Item 5.02 disclosure covering departures, elections, appointments, and/or compensatory arrangements, but the actual prose content was not provided. Without the specific details of what occurred (e.g., whether an executive departed, was appointed, received compensation, or some combination), I cannot reliably classify this into a more specific event type. I am marking it as material because Item 5.02 disclosures typically involve material executive changes, but the confidence is low due to missing content.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:38:05.690972+00:00","company_name":"","ticker":null,"filing_date":""}]}],"classifications":[{"id":3653,"accession_number":"0001213900-26-064278","item_number":"5.02","item_title":"Departure of Directors or Certain","event_type":"other_material","event_domain":"catchall","is_material":true,"confidence":0.35,"reasoning":"The section header indicates Item 5.02 disclosure covering departures, elections, appointments, and/or compensatory arrangements, but the actual prose content was not provided. Without the specific details of what occurred (e.g., whether an executive departed, was appointed, received compensation, or some combination), I cannot reliably classify this into a more specific event type. I am marking it as material because Item 5.02 disclosures typically involve material executive changes, but the confidence is low due to missing content.","classifier_version":"claude-haiku-4-5-20251001+prompt-9e0ffca5","taxonomy_version":"v1","classified_at":"2026-06-03T02:38:05.690972+00:00","company_name":"Allarity Therapeutics, Inc.","ticker":"ALLR","filing_date":"2026-06-02"}]}